FindTrial
Sign In

paravertebral injection of autologous fat as a new therapy for herpes zoster pain

paravertebral injection of autologous fat as a new therapy for herpes zoster pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900025416
Enrollment
Unknown
Registered
2019-08-26
Start date
2019-09-01
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

herpes zoster

Interventions

Control group:drug therapy + nerve block
experimental group:drug therapy + fat grafting

Sponsors

Shanghai Changhai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 50 to 80 years; 2. BMI 18 to 28; 3. Herpes zoster within 1 month after onset of the rash; 4. Dermatome below C6, beyond L1.

Exclusion criteria

Exclusion criteria: 1. Coagulation abnormalities including use of coumarin anticoagulants; 2. Bacterial infection of the skin overlying the vertebra of the affected dermatome; 3. Allergy to drug or instrument used in the treatment; 4. Known serious immune disorders (eg, AIDS, malignant tumor); 5. Diabetes or other severe organ dysfunction.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale;—

Secondary

MeasureTime frame
Neuropathic Pain Symptom inventory;the MOS item short from health survey;oral drug doses;incidence of postherpetic neuralgia;—

Countries

China

Contacts

Public ContactXiong Yuanchang

Shanghai Changhai Hospital

proychxiong@163.com+86 13901911666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026